Copyright
©The Author(s) 2021.
World J Transplant. Dec 18, 2021; 11(12): 512-522
Published online Dec 18, 2021. doi: 10.5500/wjt.v11.i12.512
Published online Dec 18, 2021. doi: 10.5500/wjt.v11.i12.512
Figure 1 Population study.
INH: Isoniazid; LT: Liver transplant; TST: Tuberculin skin test.
Figure 2 Tuberculin skin test implementation between 2005 and 2012.
TST: Tuberculin skin test.
- Citation: Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522
- URL: https://www.wjgnet.com/2220-3230/full/v11/i12/512.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i12.512